Glaxosmithkline Pharmaceuticals fundamental analysis

GLAXO

2283

0.00 (0.00%)
Last updated on 30 Mar, 2026 | 15:43 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Glaxosmithkline Pharmaceuticals Fundamentals

P/E Ratio

37.49

P/B Ratio

19.1

Div. Yield

2.39

Sector P/E

58.52

Sector P/B

3.11

Sec. Div. Yield

0.6

Glaxosmithkline Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 37.49, compared to the sector average of 58.52. Its P/B Ratio stands at 19.1, while the sector’s is 3.11. In terms of returns, the stock offers a Dividend Yield of 2.39%, which is than the sector’s 0.6%.

Glaxosmithkline Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Glaxosmithkline Pharmaceuticals reflects: Price – Attractive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost